Overview

68 Ga PSMA PET/MRI for Hepatocellular Carcinoma

Status:
Active, not recruiting

Trial end date:
2022-06-01

Target enrollment:

Participant gender:

Summary

This is a pilot study to investigate the evaluate to use of a drug/radiopharmaceutical called Gallium-68 PSMA-11 (68Ga-PSMA-11) for use in PET/MRI evaluation of hepatocellular carcinoma

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Ajit H. Goenka, MD

Treatments:

Gallium 68 PSMA-11